UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
                                  -------------

                                    Form 8-K/A

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (Date of earliest event reportedly): January 25, 2005


                              OCEAN BIO-CHEM, INC.
               (Exact name of registrant as specified in charter)

    Florida                    2-70197                          59-1564329
(State  or  Other     (Commission File Number)                (I.R.S.Employer
Jurisdiction  of                                             Identification No.)
Incorporation)

               4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
                (Address of principal executive office Zip Code)

                                 (954) 587-6280
                         Registrant's telephone number,
                              including area code:

                                 Not Applicable
          (Former name or former address, if changes since last report)

     Check the  appropriate  box below if the Form 8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

     [ ] Written  communications  pursuant to Rule 425 under the  Securities Act
         (17 CFR 230.425)

     [ ] Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17
          CFR 240.14a-12)

     [ ] Pre-commencement  communications  pursuant to Rule 14d-2(b)  under the
         Exchange Act (17 CFR 240.14d-2(b))

     [ ] Pre-commencement  communications  pursuant to Rule 13e-4(c)  under the
         Exchange Act (17 CFR 240.13e-4(c))



     Item 4.01 Changes In and  Disagreement  With  Accountants on Accounting and
Financial Disclosure

           N/A

Item 9.01  Financial Statements and Exhibits.

     16.1 Letter from Berkovits,  Lago & Company, LLP, dated January 17, 2005 to
the U.S.  Securities  and  Exchange  Commission  relating  to their  reading and
concurring with the COmpany's Form 8-K/A filed on January 12, 2005.

                                   Signatures


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: January 25, 2005                      Ocean Bio-Chem, Inc.

                                            /s/ Peter G. Dornau
                                            ----------------------
                                            Peter G. Dornau
                                            Chairman of Board of Directors and
                                            Chief Executive Officer




EXHIBIT 16.1 Letter dated January 17, 2005 from Berkovits, Lago & Company,
LLP to the United States Securities and Exchange Commission


                         BERKOVITS, LAGO & COMPANY, LLP
                  Certified Public Accountants and Consultants
                     8211 West Broward Boulevard, Suite 340
                            Plantation, Florida 33324


January 17, 2005

Securities and Exchange Commission
450 Fifth Street
Washington, D.C. 20549


Commissioners:

     We have read the comments  made by Ocean  Bio-Chem,  Inc.  (copy  attached)
which we understand will be filed with the Commission,  pursuant to Item 4.01 of
Form 8-K/A,  as part of the Company's  Form 8-K/A report dated January 12, 2005.
We agree with the statements concerning our Firm in such Form 8-K/A.

Yours truly,

/s/ Berkovits, Lago & Company, LLP
----------------------------------
Berkovits, Lago & Company, LLP